GlaxoSmithKline S.A.E (EGX:BIOC)
Egypt
· Delayed Price · Currency is EGP 67.17
-0.81 (-1.19%)
At close: Apr 28, 2026
GlaxoSmithKline S.A.E Company Description
GlaxoSmithKline S.A.E engages in production of pharmaceutical chemicals.
The company is involved in manufacture of general and specialty medicines, and vaccines. GlaxoSmithKline S.A.E was founded in 1981 and is based in New Cairo, Egypt.
GlaxoSmithKline S.A.E operates as a subsidiary of Glaxo Group Limited.
GlaxoSmithKline S.A.E
| Country | Egypt |
| Founded | 1981 |
| Industry | Pharmaceutical Preparations |
| Employees | 800 |
| CEO | Heba El Morshedy |
Contact Details
Address: Boomerang Office Building - Land No. 46 New Cairo, 11835 Egypt | |
| Phone | 20 2 2618 5000 |
| Website | gsk.com |
Stock Details
| Ticker Symbol | BIOC |
| Exchange | Egyptian Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | EGP |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Heba El Morshedy | Chief Executive Officer |
| Tamer Mohamed | Chief Financial Officer |
| Mohsen Taoufils | Head of Investor Relations |